S11 Ep1: Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC

from OncLive® On Air · host OncLive® On Air

Dr Rotow discusses data that demonstrated the central nervous system activity of datopotamab deruxtecan and osimertinib in patients with NSCLC.

Episode metadata supplied by the publisher feed · Published Aug 8, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S11 Ep1: Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC

0:00 10:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 10 minutes long.

This episode was published on August 8, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!